nodes	percent_of_prediction	percent_of_DWPC	metapath
Chloramphenicol—CYP2C8—Tazarotene—psoriasis	0.0721	0.0922	CbGbCtD
Chloramphenicol—CYP3A5—Beclomethasone—psoriasis	0.0697	0.0892	CbGbCtD
Chloramphenicol—CYP2C8—Cholecalciferol—psoriasis	0.0308	0.0394	CbGbCtD
Chloramphenicol—SLC22A6—Cyclosporine—psoriasis	0.0307	0.0393	CbGbCtD
Chloramphenicol—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.0297	0.038	CbGbCtD
Chloramphenicol—CYP3A7—Hydrocortisone—psoriasis	0.0297	0.038	CbGbCtD
Chloramphenicol—CYP3A7—Cyclosporine—psoriasis	0.028	0.0359	CbGbCtD
Chloramphenicol—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.028	0.0359	CbGbCtD
Chloramphenicol—CYP3A5—Mycophenolate mofetil—psoriasis	0.0277	0.0355	CbGbCtD
Chloramphenicol—CYP2C8—Mycophenolate mofetil—psoriasis	0.0267	0.0341	CbGbCtD
Chloramphenicol—CYP2C19—Cholecalciferol—psoriasis	0.0258	0.033	CbGbCtD
Chloramphenicol—CYP3A4—Calcitriol—psoriasis	0.0242	0.031	CbGbCtD
Chloramphenicol—CYP3A5—Hydrocortisone—psoriasis	0.0223	0.0285	CbGbCtD
Chloramphenicol—CYP2C9—Cholecalciferol—psoriasis	0.0215	0.0275	CbGbCtD
Chloramphenicol—CYP2C8—Hydrocortisone—psoriasis	0.0214	0.0274	CbGbCtD
Chloramphenicol—CYP3A5—Cyclosporine—psoriasis	0.021	0.0269	CbGbCtD
Chloramphenicol—CYP2C8—Cyclosporine—psoriasis	0.0202	0.0259	CbGbCtD
Chloramphenicol—CYP3A4—Methoxsalen—psoriasis	0.0188	0.0241	CbGbCtD
Chloramphenicol—CYP3A7—Dexamethasone—psoriasis	0.0185	0.0236	CbGbCtD
Chloramphenicol—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.0185	0.0236	CbGbCtD
Chloramphenicol—CYP2C19—Prednisone—psoriasis	0.0179	0.0229	CbGbCtD
Chloramphenicol—CYP2C19—Cyclosporine—psoriasis	0.017	0.0217	CbGbCtD
Chloramphenicol—SLC22A6—Methotrexate—psoriasis	0.0163	0.0208	CbGbCtD
Chloramphenicol—CYP2C9—Cyclosporine—psoriasis	0.0141	0.018	CbGbCtD
Chloramphenicol—CYP3A5—Dexamethasone—psoriasis	0.0138	0.0177	CbGbCtD
Chloramphenicol—CYP2C8—Dexamethasone—psoriasis	0.0133	0.017	CbGbCtD
Chloramphenicol—CYP3A4—Cholecalciferol—psoriasis	0.0125	0.016	CbGbCtD
Chloramphenicol—CYP2C19—Dexamethasone—psoriasis	0.0112	0.0143	CbGbCtD
Chloramphenicol—CYP3A4—Triamcinolone—psoriasis	0.0108	0.0138	CbGbCtD
Chloramphenicol—CYP3A4—Mycophenolate mofetil—psoriasis	0.0108	0.0138	CbGbCtD
Chloramphenicol—CYP2C9—Dexamethasone—psoriasis	0.00929	0.0119	CbGbCtD
Chloramphenicol—CYP3A4—Betamethasone—psoriasis	0.00928	0.0119	CbGbCtD
Chloramphenicol—CYP3A4—Prednisolone—psoriasis	0.00916	0.0117	CbGbCtD
Chloramphenicol—CYP3A4—Hydrocortisone—psoriasis	0.00868	0.0111	CbGbCtD
Chloramphenicol—CYP3A4—Prednisone—psoriasis	0.00865	0.0111	CbGbCtD
Chloramphenicol—CYP3A4—Cyclosporine—psoriasis	0.0082	0.0105	CbGbCtD
Chloramphenicol—CYP3A4—Dexamethasone—psoriasis	0.0054	0.00691	CbGbCtD
Chloramphenicol—CYP2C8—CYP2E1 reactions—CYP2S1—psoriasis	0.00179	0.0502	CbGpPWpGaD
Chloramphenicol—CYP3A7—Xenobiotics—CYP2S1—psoriasis	0.00177	0.0497	CbGpPWpGaD
Chloramphenicol—CYP2C19—CYP2E1 reactions—CYP2S1—psoriasis	0.00159	0.0448	CbGpPWpGaD
Chloramphenicol—CYP2C9—CYP2E1 reactions—CYP2S1—psoriasis	0.00145	0.0409	CbGpPWpGaD
Chloramphenicol—CD55—Complement cascade—CRP—psoriasis	0.00141	0.0396	CbGpPWpGaD
Chloramphenicol—CYP3A5—Xenobiotics—CYP2S1—psoriasis	0.00128	0.0359	CbGpPWpGaD
Chloramphenicol—CYP2C8—Xenobiotics—CYP2S1—psoriasis	0.00111	0.0311	CbGpPWpGaD
Chloramphenicol—CYP2C19—Xenobiotics—CYP2S1—psoriasis	0.000988	0.0278	CbGpPWpGaD
Chloramphenicol—CD55—GPCR ligand binding—HCAR2—psoriasis	0.00094	0.0264	CbGpPWpGaD
Chloramphenicol—CYP2C9—Xenobiotics—CYP2S1—psoriasis	0.000901	0.0253	CbGpPWpGaD
Chloramphenicol—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000734	0.0206	CbGpPWpGaD
Chloramphenicol—CYP3A7—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000724	0.0204	CbGpPWpGaD
Chloramphenicol—CD55—Immune System—KIR2DS1—psoriasis	0.000619	0.0174	CbGpPWpGaD
Chloramphenicol—CYP3A7—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000595	0.0167	CbGpPWpGaD
Chloramphenicol—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000594	0.0167	CbGpPWpGaD
Chloramphenicol—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00053	0.0149	CbGpPWpGaD
Chloramphenicol—CYP3A5—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000523	0.0147	CbGpPWpGaD
Chloramphenicol—CD55—GPCR ligand binding—CCL20—psoriasis	0.000488	0.0137	CbGpPWpGaD
Chloramphenicol—CD55—Signaling by GPCR—HCAR2—psoriasis	0.000482	0.0136	CbGpPWpGaD
Chloramphenicol—CD55—Innate Immune System—DDX58—psoriasis	0.000479	0.0135	CbGpPWpGaD
Chloramphenicol—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000459	0.0129	CbGpPWpGaD
Chloramphenicol—CYP2C8—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000453	0.0128	CbGpPWpGaD
Chloramphenicol—CYP3A5—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00043	0.0121	CbGpPWpGaD
Chloramphenicol—Abdominal distension—Hydrocortisone—psoriasis	0.000412	0.00225	CcSEcCtD
Chloramphenicol—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00041	0.0115	CbGpPWpGaD
Chloramphenicol—Hypersensitivity—Calcitriol—psoriasis	0.000408	0.00223	CcSEcCtD
Chloramphenicol—Feeling abnormal—Acitretin—psoriasis	0.000406	0.00221	CcSEcCtD
Chloramphenicol—CYP2C19—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000405	0.0114	CbGpPWpGaD
Chloramphenicol—Neuropathy peripheral—Cyclosporine—psoriasis	0.000402	0.0022	CcSEcCtD
Chloramphenicol—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—psoriasis	0.0004	0.00219	CcSEcCtD
Chloramphenicol—Stomatitis—Cyclosporine—psoriasis	0.0004	0.00219	CcSEcCtD
Chloramphenicol—Neuropathy peripheral—Mycophenolate mofetil—psoriasis	0.000393	0.00214	CcSEcCtD
Chloramphenicol—Pruritus—Calcitriol—psoriasis	0.000391	0.00214	CcSEcCtD
Chloramphenicol—Rash—Methoxsalen—psoriasis	0.000391	0.00214	CcSEcCtD
Chloramphenicol—Dermatitis—Methoxsalen—psoriasis	0.000391	0.00214	CcSEcCtD
Chloramphenicol—Urticaria—Acitretin—psoriasis	0.000391	0.00214	CcSEcCtD
Chloramphenicol—Stomatitis—Mycophenolate mofetil—psoriasis	0.00039	0.00213	CcSEcCtD
Chloramphenicol—Body temperature increased—Acitretin—psoriasis	0.000389	0.00212	CcSEcCtD
Chloramphenicol—Headache—Methoxsalen—psoriasis	0.000389	0.00212	CcSEcCtD
Chloramphenicol—Body temperature increased—Fluocinolone Acetonide—psoriasis	0.000388	0.00212	CcSEcCtD
Chloramphenicol—Abdominal distension—Triamcinolone—psoriasis	0.000388	0.00212	CcSEcCtD
Chloramphenicol—Aplastic anaemia—Methotrexate—psoriasis	0.000381	0.00208	CcSEcCtD
Chloramphenicol—Nervous system disorder—Hydroxyurea—psoriasis	0.000379	0.00207	CcSEcCtD
Chloramphenicol—Diarrhoea—Calcitriol—psoriasis	0.000379	0.00207	CcSEcCtD
Chloramphenicol—Thrombocytopenia—Hydroxyurea—psoriasis	0.000378	0.00207	CcSEcCtD
Chloramphenicol—Skin disorder—Hydroxyurea—psoriasis	0.000375	0.00205	CcSEcCtD
Chloramphenicol—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000374	0.0105	CbGpPWpGaD
Chloramphenicol—Agranulocytosis—Mycophenolate mofetil—psoriasis	0.000374	0.00204	CcSEcCtD
Chloramphenicol—CYP2C8—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000372	0.0105	CbGpPWpGaD
Chloramphenicol—CYP2C9—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000369	0.0104	CbGpPWpGaD
Chloramphenicol—Nausea—Methoxsalen—psoriasis	0.000369	0.00201	CcSEcCtD
Chloramphenicol—Neuropathy peripheral—Prednisolone—psoriasis	0.000366	0.002	CcSEcCtD
Chloramphenicol—Hypersensitivity—Acitretin—psoriasis	0.000363	0.00198	CcSEcCtD
Chloramphenicol—Hypersensitivity—Fluocinolone Acetonide—psoriasis	0.000362	0.00197	CcSEcCtD
Chloramphenicol—Neuropathy peripheral—Hydrocortisone—psoriasis	0.000358	0.00195	CcSEcCtD
Chloramphenicol—Leukopenia—Mycophenolic acid—psoriasis	0.000355	0.00194	CcSEcCtD
Chloramphenicol—Vomiting—Calcitriol—psoriasis	0.000352	0.00192	CcSEcCtD
Chloramphenicol—Rash—Calcitriol—psoriasis	0.000349	0.0019	CcSEcCtD
Chloramphenicol—Dermatitis—Calcitriol—psoriasis	0.000349	0.0019	CcSEcCtD
Chloramphenicol—Pruritus—Acitretin—psoriasis	0.000348	0.0019	CcSEcCtD
Chloramphenicol—Pruritus—Fluocinolone Acetonide—psoriasis	0.000347	0.0019	CcSEcCtD
Chloramphenicol—Headache—Calcitriol—psoriasis	0.000347	0.00189	CcSEcCtD
Chloramphenicol—Diarrhoea—Acitretin—psoriasis	0.000337	0.00184	CcSEcCtD
Chloramphenicol—Neuropathy peripheral—Triamcinolone—psoriasis	0.000337	0.00184	CcSEcCtD
Chloramphenicol—Eye disorder—Mycophenolate mofetil—psoriasis	0.000336	0.00183	CcSEcCtD
Chloramphenicol—Diarrhoea—Fluocinolone Acetonide—psoriasis	0.000336	0.00183	CcSEcCtD
Chloramphenicol—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—psoriasis	0.000335	0.00183	CcSEcCtD
Chloramphenicol—Gastrointestinal disorder—Hydroxyurea—psoriasis	0.000334	0.00182	CcSEcCtD
Chloramphenicol—CYP2C19—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000332	0.00935	CbGpPWpGaD
Chloramphenicol—Pain—Hydroxyurea—psoriasis	0.00033	0.0018	CcSEcCtD
Chloramphenicol—CD55—Innate Immune System—IFIH1—psoriasis	0.000329	0.00927	CbGpPWpGaD
Chloramphenicol—Nausea—Calcitriol—psoriasis	0.000329	0.00179	CcSEcCtD
Chloramphenicol—Confusional state—Mycophenolic acid—psoriasis	0.000326	0.00178	CcSEcCtD
Chloramphenicol—Feeling abnormal—Hydroxyurea—psoriasis	0.000318	0.00174	CcSEcCtD
Chloramphenicol—Shock—Mycophenolic acid—psoriasis	0.000318	0.00174	CcSEcCtD
Chloramphenicol—Nervous system disorder—Mycophenolic acid—psoriasis	0.000317	0.00173	CcSEcCtD
Chloramphenicol—Thrombocytopenia—Mycophenolic acid—psoriasis	0.000317	0.00173	CcSEcCtD
Chloramphenicol—CD55—Immune System—ERAP1—psoriasis	0.000317	0.00891	CbGpPWpGaD
Chloramphenicol—CYP3A7—Biological oxidations—CYP2S1—psoriasis	0.000316	0.00889	CbGpPWpGaD
Chloramphenicol—Skin disorder—Mycophenolic acid—psoriasis	0.000314	0.00172	CcSEcCtD
Chloramphenicol—Vomiting—Acitretin—psoriasis	0.000313	0.00171	CcSEcCtD
Chloramphenicol—CD55—Innate Immune System—HLA-C—psoriasis	0.000312	0.00879	CbGpPWpGaD
Chloramphenicol—Vomiting—Fluocinolone Acetonide—psoriasis	0.000312	0.0017	CcSEcCtD
Chloramphenicol—CYP3A7—Metapathway biotransformation—CYP2S1—psoriasis	0.000312	0.00877	CbGpPWpGaD
Chloramphenicol—Rash—Acitretin—psoriasis	0.00031	0.00169	CcSEcCtD
Chloramphenicol—Dermatitis—Acitretin—psoriasis	0.00031	0.00169	CcSEcCtD
Chloramphenicol—Rash—Fluocinolone Acetonide—psoriasis	0.000309	0.00169	CcSEcCtD
Chloramphenicol—Dermatitis—Fluocinolone Acetonide—psoriasis	0.000309	0.00169	CcSEcCtD
Chloramphenicol—CD55—Innate Immune System—TNFAIP3—psoriasis	0.000308	0.00868	CbGpPWpGaD
Chloramphenicol—Headache—Acitretin—psoriasis	0.000308	0.00168	CcSEcCtD
Chloramphenicol—Headache—Fluocinolone Acetonide—psoriasis	0.000308	0.00168	CcSEcCtD
Chloramphenicol—Abdominal distension—Prednisone—psoriasis	0.000307	0.00167	CcSEcCtD
Chloramphenicol—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.000306	0.00862	CbGpPWpGaD
Chloramphenicol—Eye disorder—Hydrocortisone—psoriasis	0.000306	0.00167	CcSEcCtD
Chloramphenicol—Neuropathy peripheral—Betamethasone—psoriasis	0.000306	0.00167	CcSEcCtD
Chloramphenicol—Neuropathy peripheral—Dexamethasone—psoriasis	0.000306	0.00167	CcSEcCtD
Chloramphenicol—Body temperature increased—Hydroxyurea—psoriasis	0.000306	0.00167	CcSEcCtD
Chloramphenicol—CYP2C9—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000303	0.00853	CbGpPWpGaD
Chloramphenicol—Immune system disorder—Hydrocortisone—psoriasis	0.000296	0.00162	CcSEcCtD
Chloramphenicol—Angioedema—Cyclosporine—psoriasis	0.000293	0.0016	CcSEcCtD
Chloramphenicol—Nausea—Acitretin—psoriasis	0.000292	0.0016	CcSEcCtD
Chloramphenicol—Nausea—Fluocinolone Acetonide—psoriasis	0.000292	0.00159	CcSEcCtD
Chloramphenicol—Leukopenia—Cyclosporine—psoriasis	0.000287	0.00157	CcSEcCtD
Chloramphenicol—Angioedema—Mycophenolate mofetil—psoriasis	0.000286	0.00156	CcSEcCtD
Chloramphenicol—CD55—Signaling Pathways—HCAR2—psoriasis	0.000285	0.00802	CbGpPWpGaD
Chloramphenicol—Hypersensitivity—Hydroxyurea—psoriasis	0.000285	0.00155	CcSEcCtD
Chloramphenicol—Leukopenia—Mycophenolate mofetil—psoriasis	0.00028	0.00153	CcSEcCtD
Chloramphenicol—Gastrointestinal disorder—Mycophenolic acid—psoriasis	0.000279	0.00153	CcSEcCtD
Chloramphenicol—CD55—Immune System—DDX58—psoriasis	0.000279	0.00784	CbGpPWpGaD
Chloramphenicol—Pain—Mycophenolic acid—psoriasis	0.000277	0.00151	CcSEcCtD
Chloramphenicol—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—psoriasis	0.000271	0.00148	CcSEcCtD
Chloramphenicol—Angioedema—Prednisolone—psoriasis	0.000267	0.00146	CcSEcCtD
Chloramphenicol—Feeling abnormal—Mycophenolic acid—psoriasis	0.000267	0.00146	CcSEcCtD
Chloramphenicol—Neuropathy peripheral—Prednisone—psoriasis	0.000266	0.00145	CcSEcCtD
Chloramphenicol—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—psoriasis	0.000265	0.00144	CcSEcCtD
Chloramphenicol—Diarrhoea—Hydroxyurea—psoriasis	0.000264	0.00144	CcSEcCtD
Chloramphenicol—Confusional state—Cyclosporine—psoriasis	0.000264	0.00144	CcSEcCtD
Chloramphenicol—Anaphylactic shock—Cyclosporine—psoriasis	0.000262	0.00143	CcSEcCtD
Chloramphenicol—Eye disorder—Betamethasone—psoriasis	0.000262	0.00143	CcSEcCtD
Chloramphenicol—Eye disorder—Dexamethasone—psoriasis	0.000262	0.00143	CcSEcCtD
Chloramphenicol—Angioedema—Hydrocortisone—psoriasis	0.000261	0.00142	CcSEcCtD
Chloramphenicol—CD55—Innate Immune System—HLA-E—psoriasis	0.000259	0.00729	CbGpPWpGaD
Chloramphenicol—Confusional state—Mycophenolate mofetil—psoriasis	0.000258	0.00141	CcSEcCtD
Chloramphenicol—Nervous system disorder—Cyclosporine—psoriasis	0.000257	0.0014	CcSEcCtD
Chloramphenicol—Thrombocytopenia—Cyclosporine—psoriasis	0.000256	0.0014	CcSEcCtD
Chloramphenicol—Body temperature increased—Mycophenolic acid—psoriasis	0.000256	0.0014	CcSEcCtD
Chloramphenicol—Anaphylactic shock—Mycophenolate mofetil—psoriasis	0.000255	0.00139	CcSEcCtD
Chloramphenicol—Skin disorder—Cyclosporine—psoriasis	0.000254	0.00139	CcSEcCtD
Chloramphenicol—Shock—Mycophenolate mofetil—psoriasis	0.000251	0.00137	CcSEcCtD
Chloramphenicol—CD55—Signaling by GPCR—CCL20—psoriasis	0.000251	0.00705	CbGpPWpGaD
Chloramphenicol—Nervous system disorder—Mycophenolate mofetil—psoriasis	0.000251	0.00137	CcSEcCtD
Chloramphenicol—Thrombocytopenia—Mycophenolate mofetil—psoriasis	0.00025	0.00137	CcSEcCtD
Chloramphenicol—Skin disorder—Mycophenolate mofetil—psoriasis	0.000248	0.00135	CcSEcCtD
Chloramphenicol—CD55—Signaling Pathways—TAGAP—psoriasis	0.000247	0.00695	CbGpPWpGaD
Chloramphenicol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000247	0.00694	CbGpPWpGaD
Chloramphenicol—Vomiting—Hydroxyurea—psoriasis	0.000246	0.00134	CcSEcCtD
Chloramphenicol—Angioedema—Triamcinolone—psoriasis	0.000245	0.00134	CcSEcCtD
Chloramphenicol—Rash—Hydroxyurea—psoriasis	0.000244	0.00133	CcSEcCtD
Chloramphenicol—Dermatitis—Hydroxyurea—psoriasis	0.000243	0.00133	CcSEcCtD
Chloramphenicol—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000243	0.00685	CbGpPWpGaD
Chloramphenicol—Headache—Hydroxyurea—psoriasis	0.000242	0.00132	CcSEcCtD
Chloramphenicol—Pancytopenia—Methotrexate—psoriasis	0.000242	0.00132	CcSEcCtD
Chloramphenicol—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—psoriasis	0.000241	0.00132	CcSEcCtD
Chloramphenicol—Anaphylactic shock—Prednisolone—psoriasis	0.000238	0.0013	CcSEcCtD
Chloramphenicol—Shock—Prednisolone—psoriasis	0.000234	0.00128	CcSEcCtD
Chloramphenicol—Anaphylactic shock—Hydrocortisone—psoriasis	0.000233	0.00127	CcSEcCtD
Chloramphenicol—Nausea—Hydroxyurea—psoriasis	0.00023	0.00125	CcSEcCtD
Chloramphenicol—Pruritus—Mycophenolic acid—psoriasis	0.000229	0.00125	CcSEcCtD
Chloramphenicol—Shock—Hydrocortisone—psoriasis	0.000229	0.00125	CcSEcCtD
Chloramphenicol—CYP3A5—Biological oxidations—CYP2S1—psoriasis	0.000228	0.00643	CbGpPWpGaD
Chloramphenicol—Nervous system disorder—Hydrocortisone—psoriasis	0.000228	0.00125	CcSEcCtD
Chloramphenicol—Eye disorder—Prednisone—psoriasis	0.000228	0.00124	CcSEcCtD
Chloramphenicol—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000226	0.00123	CcSEcCtD
Chloramphenicol—Skin disorder—Hydrocortisone—psoriasis	0.000226	0.00123	CcSEcCtD
Chloramphenicol—CYP3A5—Metapathway biotransformation—CYP2S1—psoriasis	0.000225	0.00634	CbGpPWpGaD
Chloramphenicol—Pain—Cyclosporine—psoriasis	0.000224	0.00122	CcSEcCtD
Chloramphenicol—Angioedema—Dexamethasone—psoriasis	0.000223	0.00122	CcSEcCtD
Chloramphenicol—Angioedema—Betamethasone—psoriasis	0.000223	0.00122	CcSEcCtD
Chloramphenicol—Diarrhoea—Mycophenolic acid—psoriasis	0.000221	0.00121	CcSEcCtD
Chloramphenicol—Stomatitis—Methotrexate—psoriasis	0.000221	0.00121	CcSEcCtD
Chloramphenicol—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000221	0.0012	CcSEcCtD
Chloramphenicol—Immune system disorder—Prednisone—psoriasis	0.00022	0.0012	CcSEcCtD
Chloramphenicol—Anaphylactic shock—Triamcinolone—psoriasis	0.000219	0.0012	CcSEcCtD
Chloramphenicol—Pain—Mycophenolate mofetil—psoriasis	0.000218	0.00119	CcSEcCtD
Chloramphenicol—CD55—Innate Immune System—SOCS1—psoriasis	0.000216	0.00609	CbGpPWpGaD
Chloramphenicol—Feeling abnormal—Cyclosporine—psoriasis	0.000216	0.00118	CcSEcCtD
Chloramphenicol—Shock—Triamcinolone—psoriasis	0.000216	0.00118	CcSEcCtD
Chloramphenicol—Agranulocytosis—Methotrexate—psoriasis	0.000212	0.00116	CcSEcCtD
Chloramphenicol—CD55—Immune System—ITGAL—psoriasis	0.000211	0.00594	CbGpPWpGaD
Chloramphenicol—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.00021	0.00115	CcSEcCtD
Chloramphenicol—Urticaria—Cyclosporine—psoriasis	0.000208	0.00114	CcSEcCtD
Chloramphenicol—Body temperature increased—Cyclosporine—psoriasis	0.000207	0.00113	CcSEcCtD
Chloramphenicol—Vomiting—Mycophenolic acid—psoriasis	0.000206	0.00112	CcSEcCtD
Chloramphenicol—Rash—Mycophenolic acid—psoriasis	0.000204	0.00111	CcSEcCtD
Chloramphenicol—Dermatitis—Mycophenolic acid—psoriasis	0.000204	0.00111	CcSEcCtD
Chloramphenicol—Pain—Prednisolone—psoriasis	0.000204	0.00111	CcSEcCtD
Chloramphenicol—Urticaria—Mycophenolate mofetil—psoriasis	0.000203	0.00111	CcSEcCtD
Chloramphenicol—Headache—Mycophenolic acid—psoriasis	0.000203	0.00111	CcSEcCtD
Chloramphenicol—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000202	0.0011	CcSEcCtD
Chloramphenicol—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000201	0.0011	CcSEcCtD
Chloramphenicol—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.0002	0.00562	CbGpPWpGaD
Chloramphenicol—Pain—Hydrocortisone—psoriasis	0.000199	0.00109	CcSEcCtD
Chloramphenicol—Anaphylactic shock—Dexamethasone—psoriasis	0.000199	0.00109	CcSEcCtD
Chloramphenicol—Anaphylactic shock—Betamethasone—psoriasis	0.000199	0.00109	CcSEcCtD
Chloramphenicol—CYP2C8—Biological oxidations—CYP2S1—psoriasis	0.000198	0.00557	CbGpPWpGaD
Chloramphenicol—CD55—Immune System—REL—psoriasis	0.000198	0.00556	CbGpPWpGaD
Chloramphenicol—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000197	0.00555	CbGpPWpGaD
Chloramphenicol—Feeling abnormal—Prednisolone—psoriasis	0.000196	0.00107	CcSEcCtD
Chloramphenicol—Shock—Dexamethasone—psoriasis	0.000196	0.00107	CcSEcCtD
Chloramphenicol—Shock—Betamethasone—psoriasis	0.000196	0.00107	CcSEcCtD
Chloramphenicol—CYP2C8—Metapathway biotransformation—CYP2S1—psoriasis	0.000195	0.00549	CbGpPWpGaD
Chloramphenicol—Nervous system disorder—Betamethasone—psoriasis	0.000195	0.00106	CcSEcCtD
Chloramphenicol—Nervous system disorder—Dexamethasone—psoriasis	0.000195	0.00106	CcSEcCtD
Chloramphenicol—Thrombocytopenia—Dexamethasone—psoriasis	0.000195	0.00106	CcSEcCtD
Chloramphenicol—Thrombocytopenia—Betamethasone—psoriasis	0.000195	0.00106	CcSEcCtD
Chloramphenicol—Angioedema—Prednisone—psoriasis	0.000194	0.00106	CcSEcCtD
Chloramphenicol—Hypersensitivity—Cyclosporine—psoriasis	0.000193	0.00105	CcSEcCtD
Chloramphenicol—Nausea—Mycophenolic acid—psoriasis	0.000192	0.00105	CcSEcCtD
Chloramphenicol—CD55—Immune System—IFIH1—psoriasis	0.000192	0.0054	CbGpPWpGaD
Chloramphenicol—Feeling abnormal—Hydrocortisone—psoriasis	0.000192	0.00105	CcSEcCtD
Chloramphenicol—Eye disorder—Methotrexate—psoriasis	0.00019	0.00104	CcSEcCtD
Chloramphenicol—Urticaria—Prednisolone—psoriasis	0.000189	0.00103	CcSEcCtD
Chloramphenicol—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000188	0.00103	CcSEcCtD
Chloramphenicol—Pain—Triamcinolone—psoriasis	0.000187	0.00102	CcSEcCtD
Chloramphenicol—Pruritus—Cyclosporine—psoriasis	0.000185	0.00101	CcSEcCtD
Chloramphenicol—Urticaria—Hydrocortisone—psoriasis	0.000185	0.00101	CcSEcCtD
Chloramphenicol—CD55—Innate Immune System—HLA-B—psoriasis	0.000185	0.0052	CbGpPWpGaD
Chloramphenicol—Immune system disorder—Methotrexate—psoriasis	0.000184	0.001	CcSEcCtD
Chloramphenicol—Body temperature increased—Hydrocortisone—psoriasis	0.000184	0.001	CcSEcCtD
Chloramphenicol—CD55—Immune System—HLA-C—psoriasis	0.000182	0.00512	CbGpPWpGaD
Chloramphenicol—Pruritus—Mycophenolate mofetil—psoriasis	0.000181	0.000987	CcSEcCtD
Chloramphenicol—Feeling abnormal—Triamcinolone—psoriasis	0.000181	0.000986	CcSEcCtD
Chloramphenicol—CD55—Immune System—TNFAIP3—psoriasis	0.00018	0.00505	CbGpPWpGaD
Chloramphenicol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000179	0.000979	CcSEcCtD
Chloramphenicol—Diarrhoea—Cyclosporine—psoriasis	0.000179	0.000978	CcSEcCtD
Chloramphenicol—CYP2C19—Biological oxidations—CYP2S1—psoriasis	0.000177	0.00497	CbGpPWpGaD
Chloramphenicol—Hypersensitivity—Prednisolone—psoriasis	0.000176	0.000959	CcSEcCtD
Chloramphenicol—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000175	0.000954	CcSEcCtD
Chloramphenicol—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	0.000174	0.0049	CbGpPWpGaD
Chloramphenicol—Urticaria—Triamcinolone—psoriasis	0.000174	0.00095	CcSEcCtD
Chloramphenicol—Body temperature increased—Triamcinolone—psoriasis	0.000173	0.000946	CcSEcCtD
Chloramphenicol—Anaphylactic shock—Prednisone—psoriasis	0.000173	0.000945	CcSEcCtD
Chloramphenicol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000172	0.00483	CbGpPWpGaD
Chloramphenicol—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000172	0.000937	CcSEcCtD
Chloramphenicol—Gastrointestinal disorder—Betamethasone—psoriasis	0.000172	0.000937	CcSEcCtD
Chloramphenicol—Hypersensitivity—Hydrocortisone—psoriasis	0.000171	0.000936	CcSEcCtD
Chloramphenicol—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	0.000171	0.00482	CbGpPWpGaD
Chloramphenicol—Shock—Prednisone—psoriasis	0.00017	0.00093	CcSEcCtD
Chloramphenicol—Pain—Betamethasone—psoriasis	0.00017	0.000928	CcSEcCtD
Chloramphenicol—Pain—Dexamethasone—psoriasis	0.00017	0.000928	CcSEcCtD
Chloramphenicol—Nervous system disorder—Prednisone—psoriasis	0.00017	0.000927	CcSEcCtD
Chloramphenicol—Skin disorder—Prednisone—psoriasis	0.000168	0.000918	CcSEcCtD
Chloramphenicol—Vomiting—Cyclosporine—psoriasis	0.000166	0.000909	CcSEcCtD
Chloramphenicol—Rash—Cyclosporine—psoriasis	0.000165	0.000901	CcSEcCtD
Chloramphenicol—Dermatitis—Cyclosporine—psoriasis	0.000165	0.000901	CcSEcCtD
Chloramphenicol—Pruritus—Hydrocortisone—psoriasis	0.000165	0.000899	CcSEcCtD
Chloramphenicol—Headache—Cyclosporine—psoriasis	0.000164	0.000896	CcSEcCtD
Chloramphenicol—Feeling abnormal—Betamethasone—psoriasis	0.000164	0.000895	CcSEcCtD
Chloramphenicol—Feeling abnormal—Dexamethasone—psoriasis	0.000164	0.000895	CcSEcCtD
Chloramphenicol—CD55—Innate Immune System—CRP—psoriasis	0.000163	0.00459	CbGpPWpGaD
Chloramphenicol—Vomiting—Mycophenolate mofetil—psoriasis	0.000162	0.000887	CcSEcCtD
Chloramphenicol—Hypersensitivity—Triamcinolone—psoriasis	0.000161	0.000881	CcSEcCtD
Chloramphenicol—Rash—Mycophenolate mofetil—psoriasis	0.000161	0.000879	CcSEcCtD
Chloramphenicol—CYP2C9—Biological oxidations—CYP2S1—psoriasis	0.000161	0.00453	CbGpPWpGaD
Chloramphenicol—Dermatitis—Mycophenolate mofetil—psoriasis	0.000161	0.000879	CcSEcCtD
Chloramphenicol—Headache—Mycophenolate mofetil—psoriasis	0.00016	0.000874	CcSEcCtD
Chloramphenicol—Diarrhoea—Hydrocortisone—psoriasis	0.000159	0.000869	CcSEcCtD
Chloramphenicol—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	0.000159	0.00447	CbGpPWpGaD
Chloramphenicol—Leukopenia—Methotrexate—psoriasis	0.000159	0.000867	CcSEcCtD
Chloramphenicol—Urticaria—Dexamethasone—psoriasis	0.000158	0.000862	CcSEcCtD
Chloramphenicol—Urticaria—Betamethasone—psoriasis	0.000158	0.000862	CcSEcCtD
Chloramphenicol—Body temperature increased—Dexamethasone—psoriasis	0.000157	0.000858	CcSEcCtD
Chloramphenicol—Body temperature increased—Betamethasone—psoriasis	0.000157	0.000858	CcSEcCtD
Chloramphenicol—Nausea—Cyclosporine—psoriasis	0.000156	0.000849	CcSEcCtD
Chloramphenicol—Pruritus—Triamcinolone—psoriasis	0.000155	0.000846	CcSEcCtD
Chloramphenicol—Nausea—Mycophenolate mofetil—psoriasis	0.000152	0.000828	CcSEcCtD
Chloramphenicol—CD55—Immune System—HLA-E—psoriasis	0.000151	0.00425	CbGpPWpGaD
Chloramphenicol—Rash—Prednisolone—psoriasis	0.00015	0.00082	CcSEcCtD
Chloramphenicol—Dermatitis—Prednisolone—psoriasis	0.00015	0.00082	CcSEcCtD
Chloramphenicol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.00015	0.000819	CcSEcCtD
Chloramphenicol—Headache—Prednisolone—psoriasis	0.000149	0.000815	CcSEcCtD
Chloramphenicol—CD55—Innate Immune System—NFKBIA—psoriasis	0.000149	0.00419	CbGpPWpGaD
Chloramphenicol—CD55—Signaling Pathways—CCL20—psoriasis	0.000148	0.00416	CbGpPWpGaD
Chloramphenicol—Vomiting—Hydrocortisone—psoriasis	0.000148	0.000808	CcSEcCtD
Chloramphenicol—Rash—Hydrocortisone—psoriasis	0.000147	0.000801	CcSEcCtD
Chloramphenicol—Dermatitis—Hydrocortisone—psoriasis	0.000147	0.0008	CcSEcCtD
Chloramphenicol—Confusional state—Methotrexate—psoriasis	0.000146	0.000797	CcSEcCtD
Chloramphenicol—Headache—Hydrocortisone—psoriasis	0.000146	0.000796	CcSEcCtD
Chloramphenicol—Anaphylactic shock—Methotrexate—psoriasis	0.000145	0.00079	CcSEcCtD
Chloramphenicol—Feeling abnormal—Prednisone—psoriasis	0.000143	0.000779	CcSEcCtD
Chloramphenicol—Nervous system disorder—Methotrexate—psoriasis	0.000142	0.000775	CcSEcCtD
Chloramphenicol—Thrombocytopenia—Methotrexate—psoriasis	0.000142	0.000774	CcSEcCtD
Chloramphenicol—Nausea—Prednisolone—psoriasis	0.000142	0.000773	CcSEcCtD
Chloramphenicol—Pruritus—Dexamethasone—psoriasis	0.000141	0.000768	CcSEcCtD
Chloramphenicol—Pruritus—Betamethasone—psoriasis	0.000141	0.000768	CcSEcCtD
Chloramphenicol—Skin disorder—Methotrexate—psoriasis	0.000141	0.000767	CcSEcCtD
Chloramphenicol—Vomiting—Triamcinolone—psoriasis	0.000139	0.000761	CcSEcCtD
Chloramphenicol—SLC22A6—SLC-mediated transmembrane transport—CP—psoriasis	0.000139	0.00392	CbGpPWpGaD
Chloramphenicol—Nausea—Hydrocortisone—psoriasis	0.000138	0.000755	CcSEcCtD
Chloramphenicol—Rash—Triamcinolone—psoriasis	0.000138	0.000754	CcSEcCtD
Chloramphenicol—Dermatitis—Triamcinolone—psoriasis	0.000138	0.000754	CcSEcCtD
Chloramphenicol—Urticaria—Prednisone—psoriasis	0.000138	0.000751	CcSEcCtD
Chloramphenicol—Headache—Triamcinolone—psoriasis	0.000137	0.00075	CcSEcCtD
Chloramphenicol—Body temperature increased—Prednisone—psoriasis	0.000137	0.000747	CcSEcCtD
Chloramphenicol—Diarrhoea—Betamethasone—psoriasis	0.000136	0.000743	CcSEcCtD
Chloramphenicol—Diarrhoea—Dexamethasone—psoriasis	0.000136	0.000743	CcSEcCtD
Chloramphenicol—CD55—GPCR ligand binding—CXCL8—psoriasis	0.000132	0.00371	CbGpPWpGaD
Chloramphenicol—Nausea—Triamcinolone—psoriasis	0.00013	0.000711	CcSEcCtD
Chloramphenicol—Hypersensitivity—Prednisone—psoriasis	0.000128	0.000697	CcSEcCtD
Chloramphenicol—Vomiting—Betamethasone—psoriasis	0.000126	0.00069	CcSEcCtD
Chloramphenicol—Vomiting—Dexamethasone—psoriasis	0.000126	0.00069	CcSEcCtD
Chloramphenicol—CD55—Immune System—SOCS1—psoriasis	0.000126	0.00355	CbGpPWpGaD
Chloramphenicol—Rash—Betamethasone—psoriasis	0.000125	0.000684	CcSEcCtD
Chloramphenicol—Rash—Dexamethasone—psoriasis	0.000125	0.000684	CcSEcCtD
Chloramphenicol—Dermatitis—Betamethasone—psoriasis	0.000125	0.000684	CcSEcCtD
Chloramphenicol—Dermatitis—Dexamethasone—psoriasis	0.000125	0.000684	CcSEcCtD
Chloramphenicol—Gastrointestinal disorder—Methotrexate—psoriasis	0.000125	0.000682	CcSEcCtD
Chloramphenicol—Headache—Betamethasone—psoriasis	0.000125	0.00068	CcSEcCtD
Chloramphenicol—Headache—Dexamethasone—psoriasis	0.000125	0.00068	CcSEcCtD
Chloramphenicol—Pain—Methotrexate—psoriasis	0.000124	0.000676	CcSEcCtD
Chloramphenicol—Pruritus—Prednisone—psoriasis	0.000123	0.000669	CcSEcCtD
Chloramphenicol—CD55—Innate Immune System—TYK2—psoriasis	0.000122	0.00343	CbGpPWpGaD
Chloramphenicol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.00012	0.00337	CbGpPWpGaD
Chloramphenicol—Feeling abnormal—Methotrexate—psoriasis	0.000119	0.000651	CcSEcCtD
Chloramphenicol—Diarrhoea—Prednisone—psoriasis	0.000118	0.000647	CcSEcCtD
Chloramphenicol—Nausea—Betamethasone—psoriasis	0.000118	0.000645	CcSEcCtD
Chloramphenicol—Nausea—Dexamethasone—psoriasis	0.000118	0.000645	CcSEcCtD
Chloramphenicol—Urticaria—Methotrexate—psoriasis	0.000115	0.000628	CcSEcCtD
Chloramphenicol—Body temperature increased—Methotrexate—psoriasis	0.000114	0.000625	CcSEcCtD
Chloramphenicol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000113	0.00319	CbGpPWpGaD
Chloramphenicol—CD55—Immune System—CD8A—psoriasis	0.000112	0.00315	CbGpPWpGaD
Chloramphenicol—CD55—Innate Immune System—CD4—psoriasis	0.00011	0.0031	CbGpPWpGaD
Chloramphenicol—Vomiting—Prednisone—psoriasis	0.00011	0.000601	CcSEcCtD
Chloramphenicol—Rash—Prednisone—psoriasis	0.000109	0.000596	CcSEcCtD
Chloramphenicol—Dermatitis—Prednisone—psoriasis	0.000109	0.000596	CcSEcCtD
Chloramphenicol—Headache—Prednisone—psoriasis	0.000108	0.000592	CcSEcCtD
Chloramphenicol—CD55—Immune System—HLA-B—psoriasis	0.000108	0.00303	CbGpPWpGaD
Chloramphenicol—Hypersensitivity—Methotrexate—psoriasis	0.000107	0.000582	CcSEcCtD
Chloramphenicol—CYP3A4—Biological oxidations—CYP2S1—psoriasis	0.000106	0.00299	CbGpPWpGaD
Chloramphenicol—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	0.000105	0.00295	CbGpPWpGaD
Chloramphenicol—Nausea—Prednisone—psoriasis	0.000103	0.000562	CcSEcCtD
Chloramphenicol—Pruritus—Methotrexate—psoriasis	0.000102	0.000559	CcSEcCtD
Chloramphenicol—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	0.000102	0.00286	CbGpPWpGaD
Chloramphenicol—CD55—Immune System—HLA-A—psoriasis	9.97e-05	0.0028	CbGpPWpGaD
Chloramphenicol—Diarrhoea—Methotrexate—psoriasis	9.9e-05	0.000541	CcSEcCtD
Chloramphenicol—CD55—Innate Immune System—JUN—psoriasis	9.87e-05	0.00278	CbGpPWpGaD
Chloramphenicol—CD55—Immune System—CRP—psoriasis	9.51e-05	0.00267	CbGpPWpGaD
Chloramphenicol—CD55—Innate Immune System—NFKB1—psoriasis	9.5e-05	0.00267	CbGpPWpGaD
Chloramphenicol—Vomiting—Methotrexate—psoriasis	9.2e-05	0.000502	CcSEcCtD
Chloramphenicol—CYP3A4—Tryptophan metabolism—CAT—psoriasis	9.16e-05	0.00258	CbGpPWpGaD
Chloramphenicol—Rash—Methotrexate—psoriasis	9.12e-05	0.000498	CcSEcCtD
Chloramphenicol—Dermatitis—Methotrexate—psoriasis	9.12e-05	0.000498	CcSEcCtD
Chloramphenicol—CD55—Immune System—HLA-DRB1—psoriasis	9.11e-05	0.00256	CbGpPWpGaD
Chloramphenicol—Headache—Methotrexate—psoriasis	9.07e-05	0.000495	CcSEcCtD
Chloramphenicol—CD55—Immune System—ICAM1—psoriasis	8.74e-05	0.00246	CbGpPWpGaD
Chloramphenicol—CD55—Immune System—NFKBIA—psoriasis	8.67e-05	0.00244	CbGpPWpGaD
Chloramphenicol—Nausea—Methotrexate—psoriasis	8.6e-05	0.000469	CcSEcCtD
Chloramphenicol—CD55—Signaling Pathways—SOCS1—psoriasis	8.15e-05	0.00229	CbGpPWpGaD
Chloramphenicol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	7.9e-05	0.00222	CbGpPWpGaD
Chloramphenicol—CD55—Signaling by GPCR—TYK2—psoriasis	7.77e-05	0.00219	CbGpPWpGaD
Chloramphenicol—CD55—Immune System—TYK2—psoriasis	7.1e-05	0.002	CbGpPWpGaD
Chloramphenicol—SLC22A6—Transmembrane transport of small molecules—CP—psoriasis	7.07e-05	0.00199	CbGpPWpGaD
Chloramphenicol—CD55—Signaling by GPCR—CXCL8—psoriasis	6.77e-05	0.0019	CbGpPWpGaD
Chloramphenicol—SLC22A6—Transmembrane transport of small molecules—CARM1—psoriasis	6.75e-05	0.0019	CbGpPWpGaD
Chloramphenicol—CD55—Immune System—IFNG—psoriasis	6.65e-05	0.00187	CbGpPWpGaD
Chloramphenicol—CD55—Immune System—CD4—psoriasis	6.42e-05	0.00181	CbGpPWpGaD
Chloramphenicol—CYP3A7—Metabolism—NDUFA5—psoriasis	6.36e-05	0.00179	CbGpPWpGaD
Chloramphenicol—CD55—Signaling Pathways—LEP—psoriasis	6.02e-05	0.00169	CbGpPWpGaD
Chloramphenicol—CD55—Signaling Pathways—APOE—psoriasis	6.02e-05	0.00169	CbGpPWpGaD
Chloramphenicol—CD55—Innate Immune System—IL6—psoriasis	5.96e-05	0.00168	CbGpPWpGaD
Chloramphenicol—CD55—Immune System—JUN—psoriasis	5.75e-05	0.00162	CbGpPWpGaD
Chloramphenicol—CD55—Signaling Pathways—NFKBIA—psoriasis	5.61e-05	0.00158	CbGpPWpGaD
Chloramphenicol—CD55—Immune System—NFKB1—psoriasis	5.53e-05	0.00156	CbGpPWpGaD
Chloramphenicol—CYP3A7—Metabolism—CYP2S1—psoriasis	5.4e-05	0.00152	CbGpPWpGaD
Chloramphenicol—CD55—Immune System—STAT3—psoriasis	4.97e-05	0.0014	CbGpPWpGaD
Chloramphenicol—CYP3A5—Metabolism—NDUFA5—psoriasis	4.59e-05	0.00129	CbGpPWpGaD
Chloramphenicol—CD55—Signaling Pathways—TYK2—psoriasis	4.59e-05	0.00129	CbGpPWpGaD
Chloramphenicol—CD55—Signaling Pathways—CXCL8—psoriasis	4e-05	0.00112	CbGpPWpGaD
Chloramphenicol—CYP2C8—Metabolism—NDUFA5—psoriasis	3.98e-05	0.00112	CbGpPWpGaD
Chloramphenicol—CYP3A5—Metabolism—CYP2S1—psoriasis	3.91e-05	0.0011	CbGpPWpGaD
Chloramphenicol—CD55—Signaling by GPCR—IL6—psoriasis	3.8e-05	0.00107	CbGpPWpGaD
Chloramphenicol—CD55—Signaling Pathways—JUN—psoriasis	3.72e-05	0.00105	CbGpPWpGaD
Chloramphenicol—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.71e-05	0.00104	CbGpPWpGaD
Chloramphenicol—CD55—Signaling Pathways—NFKB1—psoriasis	3.58e-05	0.00101	CbGpPWpGaD
Chloramphenicol—CYP2C19—Metabolism—NDUFA5—psoriasis	3.55e-05	0.000999	CbGpPWpGaD
Chloramphenicol—CD55—Immune System—IL6—psoriasis	3.47e-05	0.000977	CbGpPWpGaD
Chloramphenicol—CYP2C8—Metabolism—CYP2S1—psoriasis	3.38e-05	0.000952	CbGpPWpGaD
Chloramphenicol—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.31e-05	0.000932	CbGpPWpGaD
Chloramphenicol—CD55—Signaling Pathways—VEGFA—psoriasis	3.25e-05	0.000913	CbGpPWpGaD
Chloramphenicol—CYP2C9—Metabolism—NDUFA5—psoriasis	3.24e-05	0.000911	CbGpPWpGaD
Chloramphenicol—CD55—Signaling Pathways—STAT3—psoriasis	3.21e-05	0.000904	CbGpPWpGaD
Chloramphenicol—CYP2C19—Metabolism—CYP2S1—psoriasis	3.02e-05	0.00085	CbGpPWpGaD
Chloramphenicol—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.02e-05	0.000849	CbGpPWpGaD
Chloramphenicol—CYP2C9—Metabolism—CYP2S1—psoriasis	2.75e-05	0.000775	CbGpPWpGaD
Chloramphenicol—CYP3A7—Metabolism—CARM1—psoriasis	2.64e-05	0.000742	CbGpPWpGaD
Chloramphenicol—CD55—Signaling Pathways—TP53—psoriasis	2.45e-05	0.00069	CbGpPWpGaD
Chloramphenicol—CD55—Signaling Pathways—IL6—psoriasis	2.25e-05	0.000632	CbGpPWpGaD
Chloramphenicol—CYP3A4—Metabolism—NDUFA5—psoriasis	2.14e-05	0.000601	CbGpPWpGaD
Chloramphenicol—CYP3A5—Metabolism—CARM1—psoriasis	1.91e-05	0.000537	CbGpPWpGaD
Chloramphenicol—CYP3A4—Metabolism—CYP2S1—psoriasis	1.82e-05	0.000511	CbGpPWpGaD
Chloramphenicol—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.77e-05	0.000499	CbGpPWpGaD
Chloramphenicol—CYP2C8—Metabolism—CARM1—psoriasis	1.65e-05	0.000465	CbGpPWpGaD
Chloramphenicol—CYP3A7—Metabolism—CAT—psoriasis	1.62e-05	0.000457	CbGpPWpGaD
Chloramphenicol—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.58e-05	0.000445	CbGpPWpGaD
Chloramphenicol—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.54e-05	0.000434	CbGpPWpGaD
Chloramphenicol—CYP2C19—Metabolism—CARM1—psoriasis	1.47e-05	0.000415	CbGpPWpGaD
Chloramphenicol—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.44e-05	0.000406	CbGpPWpGaD
Chloramphenicol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.38e-05	0.000388	CbGpPWpGaD
Chloramphenicol—CYP2C9—Metabolism—CARM1—psoriasis	1.34e-05	0.000378	CbGpPWpGaD
Chloramphenicol—CYP3A7—Metabolism—APOE—psoriasis	1.26e-05	0.000355	CbGpPWpGaD
Chloramphenicol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.26e-05	0.000354	CbGpPWpGaD
Chloramphenicol—CYP3A5—Metabolism—CAT—psoriasis	1.17e-05	0.00033	CbGpPWpGaD
Chloramphenicol—CYP3A7—Metabolism—PPARG—psoriasis	1.1e-05	0.000309	CbGpPWpGaD
Chloramphenicol—CYP2C8—Metabolism—CAT—psoriasis	1.02e-05	0.000286	CbGpPWpGaD
Chloramphenicol—CYP3A5—Metabolism—APOE—psoriasis	9.12e-06	0.000256	CbGpPWpGaD
Chloramphenicol—CYP2C19—Metabolism—CAT—psoriasis	9.07e-06	0.000255	CbGpPWpGaD
Chloramphenicol—CYP3A4—Metabolism—CARM1—psoriasis	8.87e-06	0.000249	CbGpPWpGaD
Chloramphenicol—CYP2C9—Metabolism—CAT—psoriasis	8.27e-06	0.000233	CbGpPWpGaD
Chloramphenicol—CYP3A5—Metabolism—PPARG—psoriasis	7.94e-06	0.000223	CbGpPWpGaD
Chloramphenicol—CYP2C8—Metabolism—APOE—psoriasis	7.9e-06	0.000222	CbGpPWpGaD
Chloramphenicol—CYP2C19—Metabolism—APOE—psoriasis	7.05e-06	0.000198	CbGpPWpGaD
Chloramphenicol—CYP2C8—Metabolism—PPARG—psoriasis	6.88e-06	0.000193	CbGpPWpGaD
Chloramphenicol—CYP2C9—Metabolism—APOE—psoriasis	6.43e-06	0.000181	CbGpPWpGaD
Chloramphenicol—CYP2C19—Metabolism—PPARG—psoriasis	6.14e-06	0.000173	CbGpPWpGaD
Chloramphenicol—CYP2C9—Metabolism—PPARG—psoriasis	5.6e-06	0.000157	CbGpPWpGaD
Chloramphenicol—CYP3A4—Metabolism—CAT—psoriasis	5.46e-06	0.000153	CbGpPWpGaD
Chloramphenicol—CYP3A4—Metabolism—APOE—psoriasis	4.24e-06	0.000119	CbGpPWpGaD
Chloramphenicol—CYP3A4—Metabolism—PPARG—psoriasis	3.69e-06	0.000104	CbGpPWpGaD
